Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL/SLL

Clinical trial NCT03639324 · WITHDRAWN

Trial details

NCT number: NCT03639324
Sponsor: Virginia Commonwealth University
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia CLL Relapsed CLL Refractory Chronic Lymphocytic Leukemia Relapsed Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma SLL Relapsed Small Lymphocytic Lymphoma Refractory Small Lymphocytic Lymphoma

Start date: 2020-10-02
Primary completion: 2021-10-18
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.